Broad Team Develop CRISPR-Cas13 Combination Diagnostic-Antiviral

Scientists led by a team at the Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard now report on the development of a...
Unaligned DNA sequences as shown on an LCD screen

Color, Verily to Return Actionable Genetic Data to Project Baseline Participants

Color and Verily Life Sciences said they will partner to return actionable genetic information to all participants in the Project Baseline Health Study, Verily’s...
Illustration of a damaged ribonucleic acid or  dna strand

BCH N of 1 Trial Yields Approved Therapy for Single Rare Disease Patient

The promise of precision medicine is focused on providing the right drug to the right patient at the right time. Usually that means matching...

UTC/RenRX, 3 Principals Agree to Pay $42.6M to Settle False Claims Allegations

UTC Laboratories—also known as Renaissance RX (RenRX)—and its three principals have agreed to pay a combined $42.6 million to settle federal allegations that they...
Provista Diagnostics researchers say the company's Videssa® Breast test can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce the use of traditional biopsy by up to 67%. (Source: [iStock/David Marchal)

Sequencing Method that Maps Breast Cell Differentiation Provides Insight to Cancer Development

Salk Institute researchers have used of a state-of-the-art technology known as single-nucleus (sn) assay for transposase-accessible chromatin (ATAC) sequencing (snATAC-seq) to profile how specific...

Novartis Solicits Proposals to Advance Biomarker Testing in Cancer

Novartis is soliciting proposals from patient advocacy organizations for initiatives designed to expand and improve understanding of biomarker testing among people with cancer that...
Next-Generation Sequencing Test for Cutaneous Melanoma

Single-Cell Transcriptional Analysis Predicts Melanoma Drug Response

Investigators at the Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence have just released findings from a new study...
digital dna

Artificial Intelligence Enhances Oncology

The volume of information that needs to be analyzed to make precision medicine a reality in cancer care is often beyond the realm of the human mind. That’s where artificial intelligence steps in
Invitae lab

Search and Detect (for Free): Invitae Pursues Sponsors for Free Genetic Testing Programs Targeting...

Among the challenges long faced by diagnostics developers striving to broaden the use of their tests is finding enough patients to generate enough samples,...
With NGS diagnostics

Illumina and Qiagen Enter 15-Year Diagnostics Partnership

Two leaders in genomics and molecular analysis, Illumina and QIAGEN, have announced a 15-year partnership that the companies say is aimed at increasing the...
Scroll Up